
|
June 1997 Volume 3 Number 6 p 696
EDITORIAL

Money matters p 589

  

letters to the editor

Cyclosporin and the clinical investigator p 590
Hartmann F. St�helin1: reply--Christopher R. Flowers2 & Kenneth L. Melmon3

  

LETTERS TO THE EDITOR

Importance of anti-HIV-1 antibodies p 590
Abraham Karpas1 Stephen Ash2 & Douglas Bainbridge3: reply--Paul W.H.I. Parren4, Quentin J. Sattenau5 & Dennis R. Burton4


Are leukotoxins toxic? p 592
Takeshi Ishizaki1 & Shingo Ameshima1 Shigeru Matsukawa2: reply--Bruce D. Hammock3


p27 expression and gastric carcinoma p 593
Masaki Mori1, Koshi Mimori1, Takeshi Shiraishi1, Shinji Tanaka1, Hiroaki Ueo2, Keizo Sugimachi3 & Tsuyoshi Akiyoshi1


NEWS

Tobacco industry runs scared . . . toward developing countries p 594


Drug company buys US cancer treatment clinics p 595


India backs gene therapy programme p 595


Bold action on health marks Labour's first month in office p 596


UK charities move to keep research fraud at bay p 597


Bid for pan-European allergy programme provokes controversy p 597


Sick at heart p 598


Tuskegee apology p 598


Jail ends Gajdusek saga p 598


Strict rules "could make transplants unworkable" p 598


Numbers game fuels debate on international health priorities p 599


COMMENTARY

Cardiovascular disease burden increases, NIH funding decreases p 600
Jan L. Breslow, President, American Heart Association


NEWS & VIEWS

Tracing the brain's circuitry with functional imaging p 602
Scott T. Grafton & Mahlon DeLong

  

A stimulating treatment for emphysema p 603
James C. Hogg

  

Fighting HIV-1 with IL-16 p 605
Michael Baier & Reinhard Kurth

  

Progress of the smart bomb cancer virus. p 606
Scott W. Lowe

  

Motors, channels and the sounds of silence p 608
Karen B. Avraham

  

Cytotrophoblasts: Masters of disguise p 610
Christopher W. G. Redman

  

Gene therapy: Progress, problems, prospects. p 612
Helen Blau1 & Paul Khavari2

  

REVIEW

The proto-oncogene Bcl-2 and its role in regulating apoptosis p 614
Guido Kroemer

  

ARTICLES

Detection of bladder cancer recurrence by microsatellite analysis of urine p 621
Gabriel Steiner1, Mark P. Schoenberg1, Jurgen F. Linn1, Li Mao2 & David Sidransky2,3

  

Flt3 ligand induces tumor regression and antitumor immune responses in vivo p 625
David H. Lynch1, Alice Andreasen1, Eugene Maraskovsky1, James Whitmore2, Robert E. Miller1 & JoAnn C.L. Schuh3

  

Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain p 632
Galina Selivanova1, Violetta Iotsova2, Ismail Okan1, Michael Fritsche3, Marika Str�m1, Bernd Groner3, Roland C. Grafstr�m2 & Klas G. Wiman1

  

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents p 639
Carla Heise1, Adam Sampson-Johannes1, Angelica Williams1, Frank McCormick, Daniel D. Von Hoff2 & David H. Kirn1

  

Enx (Hox11L1)-deficient mice develop myenteric neuronal hyperplasia and megacolon p 646
Senji Shirasawa1, Anne Marie R. Yunker2, Kevin A. Roth2, Gary A. Brown1, Susan Horning1 & Stanley J. Korsmeyer1

  

Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization p 651
Michael D. Lubeck1, Robert Natuk1, Maria Myagkikh2, Narender Kalyan1, Kristine Aldrich2, Faruk Sinangil3, Shabnam Alipanah2, Shri C.S. Murthy1, Pranab K. Chanda1, Stephen M. Nigida, Jr.4, Phillip D. Markham5, Susan Zolla-Pazner6, Kathy Steimer3, Mark Wade1, Marvin S. Reitz, Jr.2, Larry O. Arthur4, Satoshi Mizutani1, Alan Davis1, Paul P. Hung1, Robert C. Gallo2, Jorg Eichberg1 & Marjorie Robert-Guroff2

  

Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: Inhibition of mRNA expression p 659
Paul Zhou1, Simoy Goldstein2, Krishnakumar Devadas1, Deepanker Tewari1, & Abner Louis Notkins1

  

Prophylaxis against HIV-1 infection in chimpanzees by nevirapine, a nonnucleoside inhibitor of reverse transcriptase p 665
Peter M. Grob1, Yunzhen Cao2, Elizabeth Muchmore3, David D. Ho2, Steve Norris4, Joseph W. Pav4, Cheng-Kon Shih1, & Julian Adams

  

Globus pallidus stimulation activates the cortical motor system during alleviation of parkinsonian symptoms p 671
Karen D. Davis1, Ethan Taub1, Sylvain Houle2, Anthony E. Lang3, Jonathan O. Dostrovsky4, Ronald R. Tasker1 & Andres M. Lozano1

  

Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats p 675
Gloria De Carlo Massaro & Donald Massaro

  

Monocyte deactivation in septic patients: Restoration by IFN-* treatment p 678
Wolf-Dietrich D�cke1, Felix Randow1, Uta Syrbe1, Dietmar Krausch2, Khusru Asadullah1, Petra Reinke3, Hans-Dieter Volk1, Wolfgang Kox2

  

Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors p 682
Ignacio Melero, Walter W. Shuford, Stephanie Ashe Newby, Alejandro Aruffo, Jeffrey A. Ledbetter, Karl Erik Hellstr�m, Robert S. Mittler & Lieping Chen

  

Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo p 686
Xian-Ping Lu1, Andrea Fanjul1?3, Nathalie Picard1, Michaela Pfahl1, Deepa Rungta1, Karen Nared-Hood1, Bruce Carter3, Javier Piedrafita2, Shiping Tang2, Eric Fabbrizio2 & Magnus Pfahl1?3

  

BOOK REVIEW

The Perfect Baby: A Pragmatic Approach to Genetics p 691
by Glenn McGee; Reviewed by Bruce C. Trapnell


Variation in the Human Genome (Ciba Foundation Symposium) p 691
edited by Derek Chadwick & Gail Cardew; Reviewed by Richard R. Hudson


How to Report Statistics in Medicine: Annotated Guidelines for Authors, Editors, and Reviewers p 692
>by Thomas A. Lang & Michelle Secic, American College of Physicians; Reviewed by Michael L. Hancock


NEW TECHNOLOGY

Selectively infective phage (SIP) technology: A novel method for in vivo selection of interacting protein?ligand pairs p 694
Stefania Spada & Andreas Pl�ckthun


On the market p 696


|